XML 51 R4.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Operations and Other Comprehensive (Loss) Income - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
REVENUE      
Total revenue $ 10,977,429 $ 10,978,571 $ 12,258,451
COST OF REVENUE      
Total cost of revenue 8,394,364 9,803,883 9,418,606
GROSS PROFIT 2,583,065 1,174,688 2,839,845
OPERATING EXPENSES      
Sales and Marketing Expenses 1,459,792 1,081,567 1,473,719
General and Administrative Expenses 2,532,860 2,802,132 2,015,215
Research and Development Expenses 107,199 1,030,359 452,608
Total operating expenses 4,099,851 4,914,058 3,941,542
LOSS FROM OPERATIONS (1,516,786) (3,739,370) (1,101,697)
Assets impairment loss (14,698,853) (6,736,684) (144,520)
(Loss) Gain on disposal of subsidiary (28,648) 14,002 26,049
Other (loss) income, net 138,822 (546,655) 102,582
LOSS BEFORE INCOME TAX (16,105,465) (11,008,707) (1,117,586)
Provision for Income Taxes 207,240 211,144
NET LOSS (16,312,705) (11,219,851) (1,117,586)
Less: net loss attributable to non-controlling interest (246,321) (147,835) (35,640)
NET LOSS ATTRIBUTABLE TO THE OWNERS’ COMPANY (16,066,384) (11,072,016) (1,081,946)
OTHER COMPREHENSIVE (LOSS) INCOME      
Foreign Currency Translation Adjustment (671,902) (1,535,600) 402,273
TOTAL COMPREHENSIVE LOSS $ (16,984,607) $ (12,755,451) $ (715,313)
Loss per share - basic [1] $ (6.54) $ (10.04) $ (0.97)
Loss per share - diluted [1] $ (6.54) $ (10.04) $ (0.97)
Weighted average shares outstanding - diluted [1] 2,596,687 1,269,876 738,613
Weighted average shares outstanding - diluted [1] 2,596,687 1,269,876 738,613
Product [Member]      
REVENUE      
Total revenue $ 2,513,483 $ 2,144,218 $ 12,145,532
COST OF REVENUE      
Total cost of revenue 737,158 1,905,037 9,343,477
Service [Member]      
REVENUE      
Total revenue 8,463,946 8,834,353 112,919
COST OF REVENUE      
Total cost of revenue $ 7,657,206 $ 7,898,846 $ 75,129
[1] The shares and per share data are presented on a retroactive basis to reflect the Company’s Share Consolidation. (Note 12)